TrademarkDir
APRECIA PHARMACEUTICALS
LIVE

Serial Number

77431190

Owner

APRECIA PHARMACEUTICALS, LLC

Attorney

Brian O'Donnell

First Use Date

Feb 10, 2006

Filing Date

Mar 25, 2008

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

APRECIA PHARMACEUTICALS Trademark

Serial Number: 77431190 • Registration: 3621718

APRECIA PHARMACEUTICALS is a trademark filed by APRECIA PHARMACEUTICALS, LLC on March 25, 2008. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

APRECIA PHARMACEUTICALS, LLC (39 trademarks)

7200 Industrial Row Drive, Suite 200
Mason, OH 45040

Entity Type: 16

Aprecia Pharmaceuticals Company (23 trademarks)

2010 Cabot Boulevard West, Suite F
Langhorne, PA 19047

Entity Type: 03

Trademark Details

Filing Date

March 25, 2008

Registration Date

May 19, 2009

First Use Anywhere

February 10, 2006

First Use in Commerce

February 10, 2006

Published for Opposition

March 3, 2009

Goods & Services

Medical and pharmaceutical consultancy, namely, consultation regarding biotechnological products for use in preparing pharmaceutical and nutraceutical preparations, namely, drug delivery systems

Development of pharmaceutical and nutraceutical preparations for others; research and development in the pharmaceutical and nutraceutical fields for others

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 12, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 12, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 12, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 12, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 12, 2025 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 1, 2018 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sep 1, 2018 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 1, 2018 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 1, 2018 APRE
TEAS SECTION 8 & 9 RECEIVED
Aug 23, 2018 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
May 19, 2018 REM2
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 31, 2018 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 31, 2018 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 6, 2017 ASGN
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 10, 2017 ASCK
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 30, 2015 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 30, 2015 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 30, 2015 APRE
TEAS SECTION 8 & 15 RECEIVED
May 15, 2015 E815
REGISTERED-PRINCIPAL REGISTER
May 19, 2009 R.PR
PUBLISHED FOR OPPOSITION
Mar 3, 2009 PUBO
NOTICE OF PUBLICATION
Feb 11, 2009 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 26, 2009 PREV
ASSIGNED TO LIE
Jan 26, 2009 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 14, 2009 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 13, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 12, 2009 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 12, 2009 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 14, 2008 GNRN
NON-FINAL ACTION E-MAILED
Jul 14, 2008 GNRT
NON-FINAL ACTION WRITTEN
Jul 14, 2008 CNRT
ASSIGNED TO EXAMINER
Jun 27, 2008 DOCK
NEW APPLICATION ENTERED
Mar 28, 2008 NWAP

Related Trademarks

More from this Owner

APRECIA THE 3DP PHARMACEUTICAL COMPANY logo

APRECIA THE 3DP PHARMACEUTICAL COMPANY

APRECIA THE 3DP PHARMACEUTICAL COMPANY logo

APRECIA THE 3DP PHARMACEUTICAL COMPANY

STYNDOVI

STYNDOVI

STYNDOVI

STYNDOVI

INSTYLLIS

INSTYLLIS

KEPSTIDA

KEPSTIDA